Literature DB >> 31313512

PAPSS2-related brachyolmia: Clinical and radiological phenotype in 18 new cases.

Lucy Bownass1, Stephen Abbs2, Ruth Armstrong3, Genevieve Baujat4, Gry Behzadi5, Ragnhild Drage Berentsen6, Christine Burren7, Alistair Calder8, Valérie Cormier-Daire4, Ruth Newbury-Ecob1, Nicola Foulds9, Petur B Juliusson10,11,12, Sarina G Kant13, Henrietta Lefroy14, Sarju G Mehta3, Else Merckoll15, Caroline Michot4, Fergal Monsell16, Amaka C Offiah17, Allan Richards2, Karen Rosendahl18,19, Cecilie F Rustad20, Deborah Shears14, Kristian Tveten21, Diana Wellesley9, Paul Wordsworth22, Sarah Smithson1.   

Abstract

Brachyolmia is a skeletal dysplasia characterized by short spine-short stature, platyspondyly, and minor long bone abnormalities. We describe 18 patients, from different ethnic backgrounds and ages ranging from infancy to 19 years, with the autosomal recessive form, associated with PAPSS2. The main clinical features include disproportionate short stature with short spine associated with variable symptoms of pain, stiffness, and spinal deformity. Eight patients presented prenatally with short femora, whereas later in childhood their short-spine phenotype emerged. We observed the same pattern of changing skeletal proportion in other patients. The radiological findings included platyspondyly, irregular end plates of the elongated vertebral bodies, narrow disc spaces and short over-faced pedicles. In the limbs, there was mild shortening of femoral necks and tibiae in some patients, whereas others had minor epiphyseal or metaphyseal changes. In all patients, exome and Sanger sequencing identified homozygous or compound heterozygous PAPSS2 variants, including c.809G>A, common to white European patients. Bi-parental inheritance was established where possible. Low serum DHEAS, but not overt androgen excess was identified. Our study indicates that autosomal recessive brachyolmia occurs across continents and may be under-recognized in infancy. This condition should be considered in the differential diagnosis of short femora presenting in the second trimester.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  PAPSS2; brachyolmia; platyspondyly

Year:  2019        PMID: 31313512     DOI: 10.1002/ajmg.a.61282

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  Novel Inactivating Homozygous PAPSS2 Mutation in Two Siblings With Disproportionate Short Stature.

Authors:  E Melissa Perez-Garcia; Philip Whalen; Nursen Gurtunca
Journal:  AACE Clin Case Rep       Date:  2021-11-24

Review 2.  Sulfation Pathways During Neurodevelopment.

Authors:  Taylor Clarke; Francesca E Fernandez; Paul A Dawson
Journal:  Front Mol Biosci       Date:  2022-04-14

3.  Identification of variants in ACAN and PAPSS2 leading to spondyloepi(meta)physeal dysplasias in four Chinese families.

Authors:  Yixuan Cao; Xin Guan; Shan Li; Nan Wu; Xiumin Chen; Tao Yang; Bo Yang; Xiuli Zhao
Journal:  Mol Genet Genomic Med       Date:  2022-03-09       Impact factor: 2.473

4.  Disease-Related Protein Variants of the Highly Conserved Enzyme PAPSS2 Show Marginal Stability and Aggregation in Cells.

Authors:  Oliver Brylski; Puja Shrestha; Philip J House; Patricia Gnutt; Jonathan Wolf Mueller; Simon Ebbinghaus
Journal:  Front Mol Biosci       Date:  2022-04-08

Review 5.  Chondrodysplasias With Multiple Dislocations Caused by Defects in Glycosaminoglycan Synthesis.

Authors:  Johanne Dubail; Valérie Cormier-Daire
Journal:  Front Genet       Date:  2021-06-16       Impact factor: 4.599

6.  A Rare Case of Brachyolmia with Amelogenesis Imperfecta Caused by a New Pathogenic Splicing Variant in LTBP3.

Authors:  Elisabetta Flex; Valentina Imperatore; Giovanna Carpentieri; Alessandro Bruselles; Andrea Ciolfi; Simone Pizzi; Maria Giovanna Tedesco; Daniela Rogaia; Amedea Mencarelli; Giuseppe Di Cara; Alberto Verrotti; Stefania Troiani; Giuseppe Merla; Marco Tartaglia; Paolo Prontera
Journal:  Genes (Basel)       Date:  2021-09-12       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.